Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
about
Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosisThiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitroAn integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in RussiaSurvival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in RussiaFirst evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countriesDiscordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence CountrySensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs.Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.Use of mycobacteriophage quantitative PCR on MGIT broths for a rapid tuberculosis antibiogramDiscordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory.The future of molecular diagnostics for drug-resistant tuberculosis.Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian FederationGenomic Insight into Mechanisms of Reversion of Antibiotic Resistance in Multidrug Resistant Mycobacterium tuberculosis Induced by a Nanomolecular Iodine-Containing Complex FS-1.In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis.Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates.Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960.Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South AfricaPyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosisEvaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance SettingsCorrelating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assaySurvival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study.Canadian multicenter laboratory study for standardized second-line antimicrobial susceptibility testing of Mycobacterium tuberculosis.Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical SamplesClinical and epidemiological profiles of individuals with drug-resistant tuberculosis.Microevolution of extensively drug-resistant tuberculosis in Russia.Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.High time to use rapid tests to detect multidrug resistance in sputum smear-negative tuberculosis in Belarus.Clinical and laboratory observation of Bacillus Calmette-Guérin infections.Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.Macrocolonies (Granules) Formation as a Cause of False-Negative Results in the MGIT 960 System: Cause Analysis and Correlation with Mycobacterial Species.Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factorsEvaluation of MGIT 960 System for the Second-Line Drugs Susceptibility Testing of Mycobacterium tuberculosis.Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones in Mycobacterium tuberculosis.High rate of drug resistance among tuberculous meningitis cases in Shaanxi province, China.Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex.Fluoroquinolone resistance in Mycobacterium tuberculosis: an assessment of MGIT 960, MODS and nitrate reductase assay and fluoroquinolone cross-resistance.Extensively drug-resistant tuberculosis: new strains, new challenges.
P2860
Q24170218-5709DDAD-B2A2-4384-AC61-7B68B6CBB9AEQ24656698-DECA0C6D-2F9C-415C-B74D-98A6BC61415EQ28476208-DD208DD3-274C-46A0-BDE0-45BA3FA06613Q28478528-FDBAE2E0-15D3-486C-BBBE-455E7AB30FA4Q28534345-DFD6DEFF-92AA-4465-9C91-4971AD56C174Q28551469-9ECB52C9-EED5-4063-9EEF-F37E879D1B91Q30278816-5E5355A2-D73D-4E6B-A8BA-B86B8F7340FAQ30300560-A361A012-3B2C-4CE6-86D7-F39AA0520BB5Q30409793-056A8B6F-EB88-42DD-83D3-9E39134394DBQ30414792-05D569F4-C4F3-4F93-80F5-D4064B37C29FQ30455525-B839B041-5593-4456-B882-5346937A885CQ33417860-73F36C98-4F56-4082-95AE-BDF9DA244E34Q33645712-CBE2767C-3C41-4992-B109-E7B503CED40AQ33798527-DD50BAF8-AF9B-4C0F-B8A1-8DC38AC7E038Q34046259-48B0A3F1-7060-4638-8EA1-C0B797BEC70FQ34046282-AA3B69CC-D82C-4156-89EC-FA81081F1CA2Q34201423-BAF2C320-E926-4C4F-9471-0D89E099E10CQ34259008-F557495B-15BE-45F8-AA49-1662DE092418Q34520274-D7E199BC-F05C-4977-939D-FE559C42AEC3Q34757821-23DB13D8-2894-48D9-AD82-AE3954D889E2Q35139804-0338A097-FABE-4F1D-B7D6-F302E7551FA9Q35181330-3B5901CF-FD3F-4EC0-AD30-F9E1689E14DEQ35577316-8B3F7DC8-5D03-45D1-B91A-BBB2B56FA5C0Q35599028-AEBDCAEE-4702-42D2-93E6-A99F08DD78A9Q35757756-DF844AE7-374D-42B5-AAA7-8AD45C0CE91EQ35810687-4CFDF673-26B4-4CA0-A181-33D762A0DE0AQ35864738-D857ED60-28A5-45A8-94BE-9338E243BAD2Q35943005-7BFC9E7D-ECEE-424B-BBC8-48D594921DC0Q35944061-25BCB0B5-54DE-4B40-AAF3-9DB16616AD18Q35959145-1DAB9F43-8604-485F-B03A-9EFDBB579168Q36087053-7ED49F75-AE53-4D16-9075-61E55A5820C3Q36290285-C51216C5-A9A3-43F8-B8B6-72F443C82951Q36290565-2119A253-7FB0-4416-8B26-D9351193F5D6Q36509397-2D6814C1-E95E-47E7-9915-0746CBFD60ADQ36773017-BD08B5B2-2B75-43F1-9C6E-A85A2846BAC5Q36794791-A7CC3508-B67F-4502-B6C1-43FFE4C5B552Q36864780-7D8E65CB-236B-42FA-B775-6CE764CB06C2Q36917933-20B9D0F1-1044-4A49-9539-70312F52F4B2Q37187468-52DC2224-6357-4C7C-BBC4-D2E0F2260615Q37291363-24A8E5F3-AB5B-40B2-B2D9-935E6D76A0D0
P2860
Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@ast
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@en
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@nl
type
label
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@ast
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@en
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@nl
prefLabel
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@ast
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@en
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@nl
P2093
P2860
P921
P1476
Evaluation of MGIT 960-based a ...... of Mycobacterium tuberculosis.
@en
P2093
Annika Krüüner
Francis A Drobniewski
Malcolm D Yates
P2860
P304
P356
10.1128/JCM.44.3.811-818.2006
P407
P577
2006-03-01T00:00:00Z